BeOne Medicines AG Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	4,548	2,627	3,172	3,870	4,376
Short-Term Investments	-	-	-	665.25	2,245
Cash & Short-Term Investments	4,548	2,627	3,172	4,535	6,621
Cash Growth	73.08%	-17.16%	-30.06%	-31.50%	42.36%
Accounts Receivable	865.08	676.28	358.03	173.17	483.11
Other Receivables	21.78	32.83	37.86	25.82	17.06
Receivables	886.86	709.11	395.89	198.98	500.18
Inventory	608.23	494.99	416.12	282.35	242.63
Prepaid Expenses	55.93	49.37	88.26	83.09	138.81
Restricted Cash	41.28	9.31	11.47	0.2	0.33
Other Current Assets	93.76	101.41	119.88	107.65	111.32
Total Current Assets	6,234	3,992	4,203	5,207	7,614
Property, Plant & Equipment	1,790	1,718	1,419	955.91	705.04
Long-Term Investments	61.68	128.93	89.64	91.78	100.79
Goodwill	-	-	-	-	0.11
Other Intangible Assets	62.7	51.1	57.14	40.62	46.68
Other Long-Term Assets	40.74	31.56	35.72	83.91	69.03
Total Assets	8,189	5,921	5,805	6,379	8,536
Accounts Payable	479.04	405	315.11	294.78	262.4
Accrued Expenses	961.09	780.48	624.92	480.1	534.33
Short-Term Debt	9.06	816.95	659.79	314.83	424.74
Current Portion of Long-Term Debt	48.23	34.58	28.58	14.14	2.82
Current Portion of Leases	20.7	17.58	21.95	24.04	21.93
Current Income Taxes Payable	41.63	25.93	22.95	25.19	21.4
Current Unearned Revenue	56.71	-	-	213.86	187.41
Other Current Liabilities	212.37	134.39	136.82	101.59	144.53
Total Current Liabilities	1,829	2,215	1,810	1,469	1,600
Long-Term Debt	961.91	166.48	197.62	209.15	202.11
Long-Term Leases	52.94	44.28	22.25	34.52	43.04
Long-Term Unearned Revenue	879.22	30.32	34.2	80.2	266.64
Pension & Post-Retirement Benefits	18.17	16.41	15	7.76	7.81
Long-Term Deferred Tax Liabilities	53.21	42.01	16.49	16	14.17
Other Long-Term Liabilities	33.1	74.29	172.27	179.78	269.63
Total Liabilities	3,827	2,589	2,268	1,996	2,403
Common Stock	0.14	0.14	0.14	0.14	0.13
Additional Paid-In Capital	12,759	12,088	11,599	11,541	11,191
Retained Earnings	-8,320	-8,607	-7,962	-7,080	-5,077
Comprehensive Income & Other	-78.18	-148.99	-99.45	-77.42	17.95
Total Common Equity	4,361	3,332	3,537	4,383	6,133
Shareholders' Equity	4,361	3,332	3,537	4,383	6,133
Total Liabilities & Equity	8,189	5,921	5,805	6,379	8,536
Total Debt	1,093	1,080	930.19	596.68	694.64
Net Cash (Debt)	3,455	1,548	2,242	3,938	5,926
Net Cash Growth	123.24%	-30.96%	-43.08%	-33.54%	44.94%
Net Cash Per Share	30.45	14.70	21.47	38.19	63.87
Filing Date Shares Outstanding	110.94	106.72	104.58	104.32	102.68
Total Common Shares Outstanding	110.85	106.72	104.58	104.32	102.68
Working Capital	4,405	1,777	2,393	3,739	6,014
Book Value Per Share	39.34	31.22	33.82	42.02	59.73
Tangible Book Value	4,298	3,281	3,480	4,343	6,086
Tangible Book Value Per Share	38.78	30.75	33.28	41.63	59.27
Land	71.43	65.49	65.49	65.49	65.49
Buildings	1,188	607.86	231.66	222.45	144.08
Machinery	583.24	485.14	392.21	334.59	237.79
Construction In Progress	127.16	654.02	740.62	293.63	186.84
Leasehold Improvements	76.57	64.68	60.12	53.79	50.29

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.